Cosentyx snrdy 300MG dose-2PENML

Ended Awarded Last action

Contract number
SPE2DR26F0AVC
Awardee
Awarding agency
Obligated
$26,012

Award facts

Contract value 100% obligated
$26,012.47 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 13, 2026, for Cosentyx (cosentinumab) 300 mg, 2 pen/mL, with a ceiling value of $26,012.47. The order is issued under a DLA Troop Support Medical indefinite delivery contract valued at up to $999,999,999.00 through December 2026, which supports pharmaceutical supply globally for military healthcare programs.

Place of performance is Conshohocken, PA 19428. The order carries firm fixed pricing and no set-aside designation. Ultimate completion date is April 14, 2026.

Quick answers

Who was awarded contract SPE2DR26F0AVC?

SPE2DR26F0AVC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 13, 2026.

How much is contract SPE2DR26F0AVC worth?

The government has obligated $26,012 on SPE2DR26F0AVC.

Is contract SPE2DR26F0AVC an order under another contract?

Yes. SPE2DR26F0AVC is a delivery order under SPE2DR25D2206, an indefinite delivery contract.

Was contract SPE2DR26F0AVC competed?

The extent of competition for SPE2DR26F0AVC was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award